You still don't know when we'll get there. But we do know how far we have come. How in recent years, the meaning of the word cancer has changed. Yes, we know more than ever before. And that is why at VHIO, we share a conviction, the conviction that the next few years will be even better. That together, we can overcome the most difficult challenges. That to achieve this, we must combine talent, innovation, commitment and excellence. And that it is necessary to do so as a team, combining the efforts of all who work tirelessly to improve the quality of life of cancer patients, both from the laboratory and from clinical care and support teams. Because we want to continue translating knowledge into real benefits for people, into health and quality of life, into opportunities, using all the tools and technologies available to us, from conventional treatments, to more innovative therapies based on immunotherapy, artificial intelligence, liquid biopsy, or the development of new targeted drugs with a personalized approach, tailoring treatment to each person and each tumor type. Because every patient is different. That is why more than 30% of patients at Vall d'Hebron University Hospital are included in our clinical trials. This does not happen anywhere else in the world. We know that with the necessary resources, we can achieve advances that yesterday seemed impossible. Every clinical trial we conduct, every grant we receive, every new medical advance we publish, has a common goal, to offer new and better treatments to cancer patients. Yes. At VHIO, we are convinced that thanks to research, we can continue to improve the quality of life of many people, because we believe in what we do, and we count on the support of our patrons and all the people and institutions that believe in us and help us to achieve our goal, gain ground against cancer, and make hope grow.
